Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
Nottingham Trent University (NTU)
GB 277399933
50 Shakespeare Street
Nottingham
NG1 4FQ
UK
Contact person: Mark Lucas
Telephone: +44 1158488747
E-mail: mark.lucas@ntu.ac.uk
NUTS: UKF14
Internet address(es)
Main address: https://www.ntu.ac.uk/
Address of the buyer profile: https://uk.eu-supply.com/ctm/Company/CompanyInformation/Index/128806
I.2) Joint procurement
The contract is awarded by a central purchasing body
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Education
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Clinical Trial Manufacturing and Distribution Services
Reference number: NTU/24/2615T/ML
II.1.2) Main CPV code
33600000
II.1.3) Type of contract
Supplies
II.1.4) Short description
Nottingham Trent University required Clinical Trial Manufacturing and Distribution Services for manufacturing and distribution of fluoxetine (20mg) and a matching placebo.
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Value excluding VAT:
344 677.00
GBP
II.2) Description
II.2.2) Additional CPV code(s)
64120000
64121000
II.2.3) Place of performance
NUTS code:
UKL
UKK
UKJ
UKI
UKH
UKG
UKF
UKE
UKD
UKC
II.2.4) Description of the procurement
Nottingham Trent University required Clinical Trial Manufacturing and Distribution Services for manufacturing and distribution of fluoxetine (20mg) and a matching placebo.
II.2.5) Award criteria
Quality criterion: Technical Compliance
/ Weighting: 24
Quality criterion: Service Delivery
/ Weighting: 21
Quality criterion: Commercial
/ Weighting: 15
Quality criterion: Sustainability
/ Weighting: 10
Price
/ Weighting:
30
II.2.11) Information about options
Options:
Yes
Description of options:
Extension to initial contract period.
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Competitive procedure with negotiation
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.1) Previous publication concerning this procedure
Notice number in the OJ S:
2024/S 000-014973
IV.2.9) Information about termination of call for competition in the form of a prior information notice
The contracting authority will not award any further contracts based on the above prior information notice
Section V: Award of contract
Contract No: 2615T
Title: Clinical Trial Manufacturing and Distribution Services
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
01/01/2025
V.2.2) Information about tenders
Number of tenders received: 3
Number of tenders received from SMEs: 3
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 3
Number of tenders received by electronic means: 3
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Sharp Clinical Services UK Ltd.
05929751
Unit 28, Heol Klockner, Heads of the Valleys Industrial Estate, Rhymney, UK, NP22 5RL
Rhymney
NP22 5RL
UK
E-mail: info@sharpclinical.com
NUTS: UKL21
Internet address(es)
URL: https://www.sharpservices.com/
The contractor is an SME:
Yes
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 344 676.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.4) Procedures for review
VI.4.1) Review body
Royal Courts of Justice
Strand
London
WC2A 2LL
UK
VI.4.2) Body responsible for mediation procedures
The Royal Courts of Justice
Strand
London
WC2A 2LL
UK
VI.4.4) Service from which information about the review procedure may be obtained
Royal Courts of Justice
Strand
London
WC2A 2LL
UK
VI.5) Date of dispatch of this notice
28/03/2025